Home Clinical Topics FDA launches mobile app on antiretrovirals

FDA launches mobile app on antiretrovirals

By Cynthia Saver, MS, RN

On Jan. 29, the FDA launched an interactive database that will offer a wealth of critical information about antiretrovirals eligible for purchase under the President’s Emergency Plan for AIDS Relief (PEPFAR) program.

Read more https://www.fda.gov/news-events/press-announcements/fda-launches-mobile-friendly-database-information-life-saving-hiv-drugs-part-ongoing-mission-empower.